ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BGM vs MRK // 10Y YIELD & FRED MACRO BETA

BGM Group Ltd. (Class A) (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: BGM 2 — MRK 7
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BGM VS. MRK) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BGM MRK SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 16.60% 74.80% -58.20 MRK /gross-margins <GO>
Return on Invested Capital (ROIC) — 20.70% — TIE /roic <GO>
EV/EBITDA & P/E Valuation — 15.3x — TIE /valuation <GO>
Free Cash Flow Yield -3.09% 3.42% -6.51 MRK /fcf-yield <GO>
Operating Margin -33.20% 34.30% -67.50 MRK /operating-margins <GO>
Net Profit Margin -52.60% 28.10% -80.70 MRK /net-margins <GO>
Revenue Growth (YoY) 51.10% 1.30% +49.80 BGM /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 2.26% -2.26 MRK /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 5.19 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 7/9 -5.00 MRK /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 56.6 56.3 +0.30 BGM /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — 0.92 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 18.4x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $127.4M $368.89B -$368.76B MRK /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BGM REV MRK REV BGM GROSS % MRK GROSS % BGM FCF MRK FCF
FY 2025 $37.9M $65.01B 16.6% 74.8% -$3.9M $12.36B
FY 2024 $25.1M $64.17B 16.4% 76.3% $304.1K $18.10B
FY 2023 $46.5M $60.12B — — $312.2K $10.30B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BGM // BETA —
MRK // BETA 0.92